good point re tax losses and market cap. the other side of buying losers is that unless you have a plan to profitability,you are buying a liability that will be a drag on the P&L.
Has BUBs ever turned a profit? have the BUBs issues with their former CEO been resolved? is there a risk of adverse publicity and litigation? maybe there are reasons why it's market cap is $100m.
I would rather see 100m.spent on marketing to the elderly/US FDA, US marketing and the release of new products ie the recent new formula release announcement
if Nestle etc pick up BUBs they will have a drain on their P&L and not much to show for it. Nestle market share in China is way behind A2M. Nestle is better off buying out A2M and actually getting to top 5 spot in China
good point re tax losses and market cap. the other side of...
Add A2M (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$7.18 |
Change
0.020(0.28%) |
Mkt cap ! $5.190B | |||
| Open | High | Low | Value | Volume |
| $7.18 | $7.23 | $7.13 | $12.81M | 1.785M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 3865 | $7.18 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $7.20 | 7121 | 7 |
View Market Depth
| Last trade - 16.10pm 07/06/2024 (20 minute delay) ? |
|
|||||
|
Last
$7.18 |
Change
0.020 ( 0.20 %) |
||||
| Open | High | Low | Volume | ||
| $7.18 | $7.23 | $7.13 | 1306035 | ||
| Last updated 15.59pm 07/06/2024 ? | |||||
| A2M (ASX) Chart |